Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Reliability of tumor markers, chemokines, and metastasis-related molecules in serum.

Linkov F, Gu Y, Arslan AA, Liu M, Shore RE, Velikokhatnaya L, Koenig KL, Toniolo P, Marrangoni A, Yurkovetsky Z, Zeleniuch-Jacquotte A, Lokshin AE.

Eur Cytokine Netw. 2009 Mar;20(1):21-6. doi: 10.1684/ecn.2009.0146.

2.

Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).

Giovanella L, Ceriani L, Giardina G, Bardelli D, Tanzi F, Garancini S.

Clin Chem Lab Med. 2002 Mar;40(3):298-303.

PMID:
12005221
3.

Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia.

Molvarec A, Szarka A, Walentin S, Beko G, Karádi I, Prohászka Z, Rigó J Jr.

Clin Chim Acta. 2011 Oct 9;412(21-22):1957-62. doi: 10.1016/j.cca.2011.06.042. Epub 2011 Jul 6.

PMID:
21756887
4.

Serial analysis of serum and ascitic fluid levels of soluble adhesion molecules and chemokines in patients with spontaneous bacterial peritonitis.

Girón-González JA, Rodríguez-Ramos C, Elvira J, Galán F, Del Alamo CF, Díaz F, Martín-Herrera L.

Clin Exp Immunol. 2001 Jan;123(1):56-61.

5.

Detectability and reproducibility of plasma levels of chemokines and soluble receptors.

Agalliu I, Xue X, Cushman M, Cornell E, Hsing AW, Kaplan RC, Anastos K, Rajpathak S, Ho GY.

Results Immunol. 2013 Aug 5;3:79-84. doi: 10.1016/j.rinim.2013.07.001. eCollection 2013.

6.

Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array.

Szarka A, Rigó J Jr, Lázár L, Beko G, Molvarec A.

BMC Immunol. 2010 Dec 2;11:59. doi: 10.1186/1471-2172-11-59.

7.

Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.

Linkov F, Lisovich A, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Nolen B, Winans M, Bigbee W, Siegfried J, Lokshin A, Ferris RL.

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):102-7.

8.

Circulating inflammation markers and prospective risk for lung cancer.

Shiels MS, Pfeiffer RM, Hildesheim A, Engels EA, Kemp TJ, Park JH, Katki HA, Koshiol J, Shelton G, Caporaso NE, Pinto LA, Chaturvedi AK.

J Natl Cancer Inst. 2013 Dec 18;105(24):1871-80. doi: 10.1093/jnci/djt309. Epub 2013 Nov 18.

9.

Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.

Pappa CA, Tsirakis G, Kanellou P, Kaparou M, Stratinaki M, Xekalou A, Alegakis A, Boula A, Stathopoulos EN, Alexandrakis MG.

Cytokine. 2011 Dec;56(3):616-20. doi: 10.1016/j.cyto.2011.08.034. Epub 2011 Sep 21.

PMID:
21940178
10.

Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.

Rothenbacher D, Müller-Scholze S, Herder C, Koenig W, Kolb H.

Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):194-9. Epub 2005 Oct 20.

11.

Relationship Between Neonatal Blood Protein Concentrations and Placenta Histologic Characteristics in Extremely Low GA Newborns.

Hecht JL, Fichorova RN, Tang VF, Allred EN, McElrath TF, Leviton A; Elgan Study Investigators.

Pediatr Res. 2011 Jan;69(1):68-73. doi: 10.1203/PDR.0b013e3181fed334.

12.

Reproducibility of serum cytokines and growth factors.

Gu Y, Zeleniuch-Jacquotte A, Linkov F, Koenig KL, Liu M, Velikokhatnaya L, Shore RE, Marrangoni A, Toniolo P, Lokshin AE, Arslan AA.

Cytokine. 2009 Jan;45(1):44-9. doi: 10.1016/j.cyto.2008.10.014. Epub 2008 Dec 5.

13.

Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?

Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F.

Clin Cancer Res. 1997 Dec;3(12 Pt 1):2451-8.

14.

Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome.

Beumer W, Drexhage RC, De Wit H, Versnel MA, Drexhage HA, Cohen D.

Psychoneuroendocrinology. 2012 Dec;37(12):1901-11. doi: 10.1016/j.psyneuen.2012.04.001. Epub 2012 Apr 27.

15.

Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study.

Lee CG, Carr MC, Murdoch SJ, Mitchell E, Woods NF, Wener MH, Chandler WL, Boyko EJ, Brunzell JD.

J Clin Endocrinol Metab. 2009 Apr;94(4):1104-10. doi: 10.1210/jc.2008-0701. Epub 2009 Jan 6.

16.

Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.

Hong SC, Yoo SW, Cho GJ, Kim T, Hur JY, Park YK, Lee KW, Kim SH.

Menopause. 2007 Sep-Oct;14(5):835-40.

PMID:
17667144
17.
18.

Plasma variation and reproducibility of oxidized LDL-cholesterol and low-grade inflammation biomarkers among participants of the Malmö Diet and Cancer cohort.

Alves Dias J, Hellstrand S, Ericson U, Gullberg B, Nilsson J, Alm R, Persson M, Engström G, Nordin Fredrikson G, Hedblad B, Wirfält E.

Biomarkers. 2016 Sep;21(6):562-71. doi: 10.3109/1354750X.2016.1160431. Epub 2016 Apr 14.

PMID:
27075407
19.

Reliability of serum prolactin measurements in women.

Koenig KL, Toniolo P, Bruning PF, Bonfrer JM, Shore RE, Pasternack BS.

Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):411-4.

20.

Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions.

Xue Y, Jiang L, Cheng Q, Chen H, Yu Y, Lin Y, Yang X, Kong N, Zhu X, Xu X, Wan W, Zou H.

PLoS One. 2012;7(10):e46740. doi: 10.1371/journal.pone.0046740. Epub 2012 Oct 29.

Supplemental Content

Support Center